Maria Palasis - Oct 16, 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
President & CEO, Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Maria Palasis
Stock symbol
LYRA
Transactions as of
Oct 16, 2024
Transactions value $
$0
Form type
4
Date filed
10/18/2024, 04:05 PM
Previous filing
Mar 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Award $0 +300K $0.00 300K Oct 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on April 1, 2025, October 1, 2025 and April 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.